DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols

Hermann Neugebauer, Peter U Heuschmann, Eric Jüttler, Hermann Neugebauer, Peter U Heuschmann, Eric Jüttler

Abstract

Background: Randomized controlled trials (RCT) on the treatment of severe space-occupying infarction of the middle cerebral artery (malignant MCA infarction) showed that early decompressive hemicraniectomy (DHC) is life saving and improves outcome without promoting most severe disablity in patients aged 18-60 years. It is, however, unknown whether the results obtained in the randomized trials are reproducible in a broader population in and apart from an academical setting and whether hemicraniectomy has been implemented in clinical practice as recommended by national and international guidelines. In addition, they were not powered to answer further relevant questions, e.g. concerning the selection of patients eligible for and the timing of hemicraniectomy. Other important issues such as the acceptance of disability following hemicraniectomy, the existence of specific prognostic factors, the value of conservative therapeutic measures, and the overall complication rate related to hemicraniectomy have not been sufficiently studied yet.

Methods/design: DESTINY-R is a prospective, multicenter, open, controlled registry including a 12 months follow-up. The only inclusion criteria is unilateral ischemic MCA stroke affecting more than 50% of the MCA-territory. The primary study hypothesis is to confirm the results of the RCT (76% mRS ≤ 4 after 12 months) in the subgroup of patients additionally fulfilling the inclusion cirteria of the RCT in daily routine. Assuming a calculated proportion of 0.76 for successes and a sample size of 300 for this subgroup, the width of the 95% CI, calculated using Wilson's method, will be 0.096 with the lower bound 0.709 and the upper bound 0.805.

Discussion: The results of this study will provide information about the effectiveness of DHC in malignant MCA infarction in a broad population and a real-life situation in addition to and beyond RCT. Further prospectively obtained data will give crucial information on open questions and will be helpful in the plannig of upcomming treatment studies.

Trial registration: (ICTRP and DRKS): DRKS00000624.

References

    1. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–315. doi: 10.1001/archneur.1996.00550040037012.
    1. Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke. 1998;29:2556–2562. doi: 10.1161/01.STR.29.12.2556.
    1. Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829–836. doi: 10.4065/73.9.829.
    1. Hofmeijer J, Kapelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB. for the HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial (HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326–333. doi: 10.1016/S1474-4422(09)70047-X.
    1. Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Witte S, Jenetzky E, Hacke W. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–2525. doi: 10.1161/STROKEAHA.107.485649.
    1. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG. DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial) Stroke. 2007;38:2506–2517. doi: 10.1161/STROKEAHA.107.485235.
    1. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedek P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W. for the DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant middle cerebral artery infarction: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–222. doi: 10.1016/S1474-4422(07)70036-4.
    1. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004;35:539–543. doi: 10.1161/01.STR.0000109772.64650.18.
    1. Uhl E, Kreth FW, Elias B, Goldammer A, Hempelmann RG, Liefner M, Nowak G, Oertel M, Schmieder K, Schneider GH. Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry. 2004;75:270–274.
    1. Rabinstein AA, Mueller-Kronast N, Maramottom BV, Zazulia AR, Bamlet WR, Diringer MN, Wijdicks EFM. Factors prediciting prognosis after decompressive hemicraniectomy for hemispheric infarction. Neurology. 2006;76:891–893.
    1. Wang KW, Chang WN, Ho JT, Chang HW, Lui CC, Cheng MH, Hung KS, Wang HC, Tsai NW, Sun TK, Lu CH. Factors predictive of fatality in massive middle cerebral artery territory infarction and clinical experience of decompressive hemicraniectomy. Eur J Neurol. 2006;13:765–771. doi: 10.1111/j.1468-1331.2006.01365.x.
    1. Hofmeijer J, Algra A, Kappelle LJ, van der Worp HB. Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc Dis. 2008;25:176–184. doi: 10.1159/000113736.
    1. Puetz V, Campos CR, Eliasziw M, Hill MD, Demchuk AM. Calgary Stroke Program. Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol. 2007;6:580–581.
    1. de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke. Impact of stroke type and lesion location. Stroke. 1995;26:402–408. doi: 10.1161/01.STR.26.3.402.
    1. Vahedi K, Benoist L, Kurtz A, Mateo J, Blanquet A, Rossignol M, Amarenco P, Yelnik A, Vicaut E, Payen D, Bousser MG. Quality of life after decompressive craniectomy for malignant middle cerebral artery infarction. J Neurol Neurosurg Psychiatry. 2005;76:1181–1182. doi: 10.1136/jnnp.2004.058537.
    1. Benejam B, Sahuquillo J, Poca MA, Frascheri L, Solana E, Delgado P, Junqué C. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol. 2009;256:1126–1133. doi: 10.1007/s00415-009-5083-9.
    1. Kiphuth IC, Köhrmann M, Lichy C, Schwab S, Huttner HB. Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome. Neurocrit Care. 2010;13:380–384. doi: 10.1007/s12028-010-9449-8.
    1. Foerch C, Lang JM, Krause J, Raabe A, Sitzer M, Seifert V, Steinmetz H, Kessler KR. Functional impairment, disability, and quality of life outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Neurosurg. 2004;101:248–254. doi: 10.3171/jns.2004.101.2.0248.
    1. Sykora M, Diedler J, Jüttler E, Steiner T, Zweckberger K, Hacke W, Unterberg A. Intensive care management of acute stroke: surgical treatment. Int J Stroke. 2010;5:170–177. doi: 10.1111/j.1747-4949.2010.00426.x.
    1. Huttner HB, Jüttler E, Schwab S. Hemicraniectomy for middle cerebral artery infarction. Curr Neurol Neurosci Rep. 2008;8:526–533. doi: 10.1007/s11910-008-0083-1.
    1. Jüttler E, Schellinger PD, Aschoff A, Zweckberger K, Unterberg A, Hacke W. Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care. 2007;11:231. doi: 10.1186/cc6087.
    1. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Statistical Science. 2001;16:101–133.
    1. Bar M, Mikulik R, Skoloudík D, Czerny D, Lipina R, Klecka L, Juran V, Mracek J, Vondrácová D, Hrabalek L, Brzezny R, Dienelt J. Nationwide study of decompressive surgery for malignant supratentorial infarction in the Czech Republic: utilization and outcome predictors. Clinical article. J Neurosurg. 2010;113:897–900. doi: 10.3171/2009.10.JNS09888.
    1. Adeoye O, Hornung R, Khatri P, Ringer A, KleindorferD. The rate of hemicraniectomy for acute ischemic stroke is increasing in the United States. J Stroke Cerebrovasc Dis. 2011;20:251–254. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.006.
    1. Jüttler E, Bösel J, Amiri H, Schiller P, Limprecht R, Hacke W, Unterberg A. DESTINY II Study Group. DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke. 2011;6:79–86. doi: 10.1111/j.1747-4949.2010.00544.x.
    1. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. Springer New York Dordrecht, Heidelberg; 2010.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe